Gurbuz A K, Giardiello F M, Petersen G M, Krush A J, Offerhaus G J, Booker S V, Kerr M C, Hamilton S R
Department of Medicine, Johns Hopkins University, School of Medicine, Baltimore, Maryland.
Gut. 1994 Mar;35(3):377-81. doi: 10.1136/gut.35.3.377.
Desmoids are rare, benign fibromatous lesions, which can arise in patients with familial adenomatous polyposis (FAP), a disorder caused by germline adenomatous polyposis coli (APC) gene mutation. This study investigated the risk of desmoids in FAP, the relation between specific APC gene mutations and desmoid formation, and the clinical characteristics of FAP patients with desmoids. Eighty three of 825 FAP patients (10%) from 49 of 161 kindreds (30%) had desmoids. The absolute risk of desmoids in FAP patients was 2.56/1000 person years; comparative risk was 852 times the general population. APC gene mutations were similar in families with and without desmoids. The female/male ratio was 1.4 (p = NS). Previous abdominal surgery was noted in 68% of patients with abdominal desmoids (55% developed within five years postoperatively). Desmoid risk in FAP family members of a desmoid patient was 25% in first degree relatives v 8% in third degree relatives. Desmoids are a comparatively common complication of FAP associated with surgical trauma and familial aggregation. Desmoid development was not linked to specific APC gene mutations and was not found predominantly in women. Studies of chemopreventive therapy, given within five years after abdominal surgery, should be considered in FAP patients with a family history of desmoid disease.
硬纤维瘤是一种罕见的良性纤维瘤性病变,可发生于家族性腺瘤性息肉病(FAP)患者中,FAP是一种由种系腺瘤性息肉病基因(APC)突变引起的疾病。本研究调查了FAP患者发生硬纤维瘤的风险、特定APC基因突变与硬纤维瘤形成之间的关系,以及患有硬纤维瘤的FAP患者的临床特征。161个家系中的49个家系(30%)的825例FAP患者中有83例(10%)患有硬纤维瘤。FAP患者发生硬纤维瘤的绝对风险为2.56/1000人年;相对风险是普通人群的852倍。有和没有硬纤维瘤的家系中APC基因突变情况相似。女性/男性比例为1.4(p=无显著性差异)。68%的腹部硬纤维瘤患者有既往腹部手术史(55%在术后五年内发生)。硬纤维瘤患者的FAP家庭成员中,一级亲属发生硬纤维瘤的风险为25%,三级亲属为8%。硬纤维瘤是FAP相对常见的并发症,与手术创伤和家族聚集有关。硬纤维瘤的发生与特定的APC基因突变无关,且并非主要发生于女性。对于有硬纤维瘤疾病家族史的FAP患者,应考虑在腹部手术后五年内进行化学预防治疗的研究。